Ann: Release of Securities from Escrow, page-12

Nice find. I has a brief look but not significant enough to look deaper.
Even if they are sold they are not related to the company so we will not know as no noitice will be issued. But considering they were involved in the CF33 acquisition I would hazard a guess that they would want to wait and see how it responds in humans.

I am stoked that potental the last patient in the restrictive cohort 1 could have already had their first dose, which starts the 28 day safety clock and then cohort safety committee review for side escalation.